Portrait Flex Staining Kit
CTC Characterization
CommercialActive
Key Facts
About CelLBxHealth
CelLBxHealth is a publicly traded, commercial-stage diagnostics company leveraging its proprietary Parsortix microfluidics platform to isolate intact circulating tumor cells from a simple blood draw. Its core business involves selling the Parsortix PC1 system (clinical) and PR1 system (research), complemented by a global GCP-compliant laboratory service offering for pharma and research clients. The company is positioned in the high-growth liquid biopsy market, aiming to enable minimally invasive, repeatable testing for cancer monitoring and research across multiple solid tumor types.
View full company profile